Haemonetics (HAE) Gross Profit Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Haemonetics | 3.18 Bn | 2.93 Bn | 198.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 19.36% |
| Dec 27, 2025 | 10.97% |
| Sep 27, 2025 | 12.99% |
| Jun 28, 2025 | 16.38% |
| Mar 29, 2025 | 11.20% |
| Dec 28, 2024 | 8.61% |
| Sep 28, 2024 | 8.10% |
| Jun 29, 2024 | 8.58% |
| Mar 30, 2024 | 9.60% |
| Dec 30, 2023 | 9.85% |
| Sep 30, 2023 | 8.79% |
| Jul 1, 2023 | 14.98% |
| Apr 1, 2023 | 8.40% |
| Dec 31, 2022 | 7.36% |
| Oct 1, 2022 | 8.59% |
| Jul 2, 2022 | 9.19% |
| Apr 2, 2022 | 10.67% |
| Jan 1, 2022 | 6.51% |
| Oct 2, 2021 | 3.29% |
| Jul 3, 2021 | 3.49% |
| Apr 3, 2021 | -1.72% |
| Dec 26, 2020 | 2.01% |
| Sep 26, 2020 | 0.08% |
| Jun 27, 2020 | -2.57% |
| Mar 28, 2020 | 0.94% |
| Dec 28, 2019 | 2.78% |
| Sep 28, 2019 | 3.27% |
| Jun 29, 2019 | 1.75% |
| Mar 30, 2019 | -0.74% |
| Dec 29, 2018 | -1.78% |
| Sep 29, 2018 | -1.37% |
| Jun 30, 2018 | -5.66% |
| Mar 31, 2018 | -3.25% |
| Dec 30, 2017 | -0.32% |
| Sep 30, 2017 | 0.54% |
| Jul 1, 2017 | 0.34% |
| Apr 1, 2017 | -2.79% |
| Dec 31, 2016 | 1.05% |
| Oct 1, 2016 | 2.99% |
| Jul 2, 2016 | 0.51% |
| Apr 2, 2016 | 0.39% |
| Dec 26, 2015 | 3.09% |
| Sep 26, 2015 | 3.71% |
| Jun 27, 2015 | 3.47% |
| Mar 28, 2015 | 4.22% |
| Dec 27, 2014 | 5.50% |
| Sep 27, 2014 | 5.95% |
| Jun 28, 2014 | 5.08% |